Clinical trial · NCT06687161
Treating Insomnia in Mild Cognitive Impairment
Sponsor: Beth Israel Deaconess Medical Center
Summary
The goal of this study is to test a new way to improve sleep quality in persons living with mild cognitive impairment. The treatment combines a safe and gentle way to stimulate the brain, called transcranial magnetic stimulation, with a psychological treatment, called cognitive behavioral therapy for insomnia.
Interventions
- Transcranial Magnetic Stimulation (TMS) therapy · DEVICE
Each treatment consists of 600 TMS pulses (\~3 minutes) applied to the L-DLPFC
- Cognitive behavioral therapy for insomnia (CBT-I) · BEHAVIORAL
9-week fully-automated, Internet-delivered CBT-I program: SHUTi OASIS (Sleep Healthy Using the Internet for Older Adult Sufferers of Insomnia and Sleeplessness)
Published eligibility criteria
Verbatim from the registry. Only the site can decide how these apply to a specific patient.
Inclusion Criteria: * Aged 60 years or older * Speak and read English * Clinical diagnosis of MCI or Subjective Cognitive Impairment (SCI)-a perceived gradual worsening in cognitive ability relative to one's younger self, or peer group-reported by either the participant or informant * Reported insomnia symptoms (sleep-onset and/or sleep maintenance) that cause significant distress or impairment in social, occupational, or other areas of functioning over the past three months * Have access to an Internet-enabled computer or tablet at home, or ability to connect a BIDMC-provided tablet to the internet, with private space to complete cognitive testing * Capable of and willing to provide written informed consent Exclusion Criteria: * Evidence of significant cognitive impairment or dementia * Contraindications for TMS or MRI * Current psychological treatment for insomnia * Uncontrolled moderate-to-severe obstructive sleep apnea or other untreated sleep disorder (e.g., Restless Leg Syndrome, Periodic Limb Movement Disorder, parasomnia). Sleep apnea that is managed (e.g., regular use of a CPAP) and stable for ≥3 months is allowed. * Diagnosis of Parkinson's disease, Huntington's disease, Lewy-Body disease, or other neurological condition known to impact sleep * Current diagnosis of major psychiatric disorder (well-controlled depression or anxiety is permitted) * Current opiate/opioid use * Alcohol or drug abuse within the past year * Irregular sleep schedule (bedtime before 8pm/after 2am OR wake time before 4am/after 10am), unless participant states they are willing and able to change if prompted.
Sites (1)
- Beth Israel Deaconess Medical Center, Boston, Massachusetts · Recruiting
Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors. Registry data refreshed at most hourly; last update posted 2025-10-24.